Vitamin B12 — Benefits Deep Dive

Benefits — scientific infographic poster

Vitamin B12 (cobalamin) is the largest and most structurally complex vitamin in the human body — a cobalt-cored molecule that no plant produces and that no other nutrient can substitute for. Four distinct biochemical roles operate simultaneously: methionine synthase cofactor driving the methylation cycle (homocysteine clearance, S-adenosylmethionine (SAMe) production, DNA methylation), methylmalonyl-CoA mutase cofactor feeding the Krebs cycle for energy production, myelin synthesis support protecting every nerve in the body from demyelination, and erythroblast DNA synthesis preventing megaloblastic anemia. Each benefit page below explores one specific therapeutic application in clinical depth.

Deep-Dive Articles

🦶

Nerve Health & Neuropathy

B12 is the most feared deficiency in clinical neurology because the damage can become permanent. Deep dive into myelin sheath integrity, subacute combined degeneration of the spinal cord, peripheral neuropathy presentations, "the great masquerader" (B12 mimicking multiple sclerosis (MS), dementia, depression), methylmalonic acid (MMA) as the most sensitive marker, and the high-dose (5000 mcg) sublingual methylcobalamin used in reports on established neuropathy.

Read the deep dive →
🩸

Anemia & Hematology

The classic indication. Megaloblastic anemia mechanism (impaired DNA synthesis in erythroblasts via the methyl trap), pernicious anemia (autoimmune intrinsic-factor antibodies), the Schilling test and its modern replacements, intramuscular (IM) injection schedules (1000 mcg daily → weekly → monthly), the 1968 study by Berlin and colleagues of high-dose oral B12 without intrinsic factor in pernicious anemia, and later trials of 1000-2000 mcg/day by mouth that rely on passive absorption.

Read the deep dive →
🧠

Cognition & Methylation

Methylcobalamin as the methyl donor in homocysteine → methionine remethylation. Methylenetetrahydrofolate reductase (MTHFR) polymorphism interaction with B12 demand. The dementia connection (low B12 in 10-20% of elderly cognitive decline). Depression mechanism through S-adenosylmethionine and monoamine synthesis. The VITACOG trial, in which B12 + folate + B6 slowed the yearly rate of brain shrinkage by 53% in people with mild cognitive impairment whose homocysteine was above 13 µmol/L.

Read the deep dive →
🥗

Vegan & Absorption Issues

The two highest-risk populations: strict vegans (a review of 40 studies found deficiency in 0–86.5% of vegetarian adults and older people, highest in vegans who take no supplements; spirulina contains mostly inactive analogues, while a 2024 trial found roasted nori raised B12 levels in vegetarians) and patients on proton pump inhibitors (PPIs), H2 blockers, or metformin (10-30% of long-term metformin users develop B12 deficiency). Atrophic gastritis in 30% of adults over 60. Supplement forms studied and the methylcobalamin vs. cyanocobalamin debate.

Read the deep dive →

Back to Table of Contents

🍖 Interactive Visualization Vitamin B12’s Impossible Journey Five stages, two carrier proteins, a working stomach and one specific stretch of gut. Break any link — a proton pump inhibitor (PPI), metformin, pernicious anaemia — and absorption collapses. Launch →

Table of Contents

  1. Deep-Dive Articles
  2. Why B12 Touches So Many Systems
  3. Roasted Nori as a Food Source of Vitamin B12
  4. Vitamin B12 Tablets Compared With Injections
  5. Research Papers: Nerve Health & Neuropathy
  6. Research Papers: Anemia & Hematology
  7. Research Papers: Cognition & Methylation
  8. Research Papers: Vegan & Absorption
  9. Research Papers: Cross-Cutting (Forms, Assays, Safety)
  10. External Authoritative Resources
  11. Connections
  12. Featured Videos

Why B12 Touches So Many Systems

Most vitamins act through a single biochemical mechanism that produces a narrow range of clinical effects. B12 is unusual because it serves as the cofactor for only two enzymes in human biology — methionine synthase and methylmalonyl-CoA mutase — yet those two reactions sit at metabolic crossroads that touch nearly every organ system:

  1. Methionine synthase (methylcobalamin-dependent) — remethylates homocysteine to methionine using a methyl group donated by 5-methyltetrahydrofolate (5-MTHF). Methionine is then converted to S-adenosylmethionine, the universal methyl donor for more than 200 reactions: DNA methylation (epigenetics), myelin lipid synthesis (phosphatidylcholine, sphingomyelin), neurotransmitter synthesis (serotonin, dopamine, melatonin), creatine production, hormone metabolism. When this reaction fails, folate becomes trapped in its methylated form (the "methyl trap"), homocysteine accumulates, and methylation collapses across the genome. This drives effects on cognition, mood, and cardiovascular health.
  2. Methylmalonyl-CoA mutase (adenosylcobalamin-dependent) — converts methylmalonyl-CoA to succinyl-CoA, feeding odd-chain fatty acids, valine, isoleucine, threonine, and methionine itself into the Krebs cycle for adenosine triphosphate (ATP) production. Succinyl-CoA is also the starting substrate for heme synthesis. When this reaction fails, methylmalonic acid (MMA) accumulates — the most sensitive functional biomarker of B12 deficiency.
  3. Myelin maintenance — downstream of methionine synthase failure. S-adenosylmethionine-dependent methylation of phospholipids is required to build and repair the fatty insulation around every nerve fiber. Without B12, myelin progressively degenerates — first peripheral nerves (numbness, tingling, burning), then the dorsal and lateral spinal columns (subacute combined degeneration), then the brain (white matter lesions, atrophy, dementia). This is the mechanism behind peripheral neuropathy and the irreversible neurological damage that defines untreated B12 deficiency.
  4. Erythropoiesis — the methyl trap starves rapidly dividing erythroblasts of the thymidine they need for DNA replication, producing oversized, immature macro-ovalocytes — the picture of megaloblastic anemia. This is identical to the anemia of folate deficiency because the underlying defect is the same.

The combination of these mechanisms is why B12 deficiency presents with a bewildering diversity of symptoms across hematology, neurology, psychiatry, cardiology, and dermatology — and why it remains the great masquerader in clinical medicine, mimicking multiple sclerosis, dementia, depression, and chronic fatigue. The complex multi-step absorption process (stomach acid → haptocorrin → intrinsic factor → ileal cubilin-amnionless receptor → transcobalamin II transport) creates vulnerability at every step, which is why absorption-impaired populations — vegans without supplementation, proton pump inhibitor users, metformin users, post-bariatric patients, and adults over 60 with atrophic gastritis — carry such a high prevalence of deficiency.

Back to Table of Contents

Roasted Nori as a Food Source of Vitamin B12

Roasted purple laver (nori), the seaweed sheet used for sushi, was tested as a B12 source in a 2024 randomized trial in 30 vegetarians who took no supplements. Eating 5 g of nori a day for 4 weeks raised serum vitamin B12 by about 59 pmol/L and holotranscobalamin (the active, cell-delivered form) by 28.2 pmol/L, and lowered homocysteine by 3.7 µmol/L compared with eating no nori. A higher amount, 8 g a day, gave no extra benefit (Huang 2024).

Back to Table of Contents

Vitamin B12 Tablets Compared With Injections

A 2018 Cochrane review found three randomized trials (153 people, treated for 3 to 4 months) that compared B12 by mouth with intramuscular injections in people with B12 deficiency. In two trials, 1000 mcg a day by mouth raised blood B12 about as well as injections; in one trial, 2000 mcg a day by mouth raised it more than injections (an average of 680 pg/mL higher). Tablets cost less in the one trial that measured cost. The reviewers rated the evidence low quality, and no trial measured symptoms of deficiency (Wang 2018).

Back to Table of Contents

Research Papers: Nerve Health & Neuropathy

  1. Subacute combined degeneration of the spinal cord — PubMed: subacute combined degeneration spinal cord B12
  2. B12 deficiency peripheral neuropathy review — PubMed: B12 peripheral neuropathy
  3. Methylcobalamin vs cyanocobalamin in neurological dosing — PubMed: methyl vs cyano neurological
  4. Methylmalonic acid as functional B12 marker — PubMed: MMA functional deficiency
  5. High-dose methylcobalamin 5000 mcg for diabetic neuropathy — PubMed: high-dose methylcobalamin neuropathy
  6. B12 deficiency neurological symptoms without anemia — PubMed: Lindenbaum neuro w/o anemia
  7. Nitrous oxide-induced B12 inactivation — PubMed: nitrous oxide B12 myeloneuropathy
  8. B12 optic neuropathy — PubMed: B12 optic neuropathy
  9. B12 autonomic neuropathy presentations — PubMed: B12 autonomic neuropathy
  10. B12 and diabetic peripheral neuropathy adjunctive therapy — PubMed: B12 + diabetic neuropathy

Back to Table of Contents

Research Papers: Anemia & Hematology

  1. Pernicious anemia pathophysiology and intrinsic factor antibodies — PubMed: pernicious anemia IF antibodies
  2. Megaloblastic anemia mechanism and the methyl trap — PubMed: megaloblastic methyl trap
  3. Schilling test historical and modern alternatives — PubMed: Schilling vs holotranscobalamin
  4. Berlin H, Berlin R, Brante G. (1968). Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Medica Scandinavica, 184(4), 247-58. — PubMed PMID: 5751528
  5. Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH. (2018). Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database of Systematic Reviews, 3(3), CD004655. — PubMed PMID: 29543316
  6. Intramuscular (IM) injection schedules for severe deficiency — PubMed: IM B12 dosing protocol
  7. Holotranscobalamin as earliest deficiency marker — PubMed: holotranscobalamin early marker
  8. Hypersegmented neutrophils as sensitive indicator — PubMed: hypersegmented neutrophils
  9. Pancytopenia from severe B12 deficiency — PubMed: B12 pancytopenia
  10. Reticulocyte response to B12 repletion — PubMed: reticulocyte response
  11. Folic acid masking B12 deficiency hematology — PubMed: folate masking B12

Back to Table of Contents

Research Papers: Cognition & Methylation

  1. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H. (2010). Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One, 5(9), e12244. — PubMed PMID: 20838622
  2. B12 and Alzheimer's disease risk — PubMed: B12 Alzheimer's risk
  3. MTHFR polymorphism and B12 demand — PubMed: MTHFR x B12 interaction
  4. B12 deficiency in elderly cognitive decline (10-20% prevalence) — PubMed: B12 elderly cognitive
  5. SAMe in depression and monoamine synthesis — PubMed: SAMe depression
  6. Methionine synthase reaction and homocysteine remethylation — PubMed: methionine synthase reaction
  7. B-vitamin supplementation and stroke prevention — PubMed: B vitamins stroke
  8. White matter hyperintensities and B12 status — PubMed: white matter hyperintensities and B12
  9. Pseudodementia from B12 deficiency — PubMed: B12 pseudodementia
  10. Methylation cycle and DNA methylation epigenetics — PubMed: methylation epigenetics

The VITACOG trial (Smith 2010) gave folic acid 0.8 mg, vitamin B12 0.5 mg and vitamin B6 20 mg a day, or placebo, for 2 years to people over 70 with mild cognitive impairment (mild memory problems). In the 168 who completed brain scans, the brain shrank by 0.76% a year on the vitamins and 1.08% a year on placebo. The effect depended on homocysteine: in those starting above 13 µmol/L, the rate of shrinkage was 53% lower. Serious side effects did not differ between the groups. One author holds patents on folic acid for Alzheimer's disease, and the tablets were donated by a vitamin maker.

Back to Table of Contents

Research Papers: Vegan & Absorption

  1. Vegan B12 deficiency prevalence — PubMed: vegan B12 prevalence
  2. Pawlak R, Lester SE, Babatunde T. (2014). The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. European Journal of Clinical Nutrition, 68(5), 541-8. — PubMed PMID: 24667752
  3. Huang QN, Watanabe F, Koseki K, He RE, Lee HL, Chiu THT. (2024). Effect of roasted purple laver (nori) on vitamin B12 nutritional status of vegetarians: a dose-response trial. European Journal of Nutrition, 63(8), 3269-3279. — PubMed PMID: 39352476
  4. Nori and spirulina B12 analogues (pseudovitamin B12) — PubMed: plant B12 analogues
  5. PPI and H2 blocker B12 absorption impairment — PubMed: PPI B12 deficiency
  6. Metformin-induced B12 deficiency (10-30% long-term users) — PubMed: metformin B12 deficiency
  7. Atrophic gastritis in elderly and B12 malabsorption — PubMed: atrophic gastritis B12
  8. B12 in vegan pregnancy and infant deficiency — PubMed: vegan pregnancy infant B12
  9. Post-bariatric surgery B12 supplementation — PubMed: bariatric B12
  10. Helicobacter pylori (H. pylori) and B12 absorption — PubMed: H. pylori B12
  11. Methylcobalamin vs cyanocobalamin bioavailability — PubMed: methyl vs cyano forms
  12. Sublingual vs oral B12 absorption — PubMed: sublingual vs oral B12

Back to Table of Contents

Research Papers: Cross-Cutting (Forms, Assays, Safety)

  1. Hydroxocobalamin for cyanide poisoning — PubMed: hydroxocobalamin cyanide
  2. B12 storage and depletion kinetics (3-5 year stores) — PubMed: B12 storage kinetics
  3. Adenosylcobalamin and mitochondrial function — PubMed: adenosylcobalamin mitochondria
  4. Cubilin-amnionless ileal absorption receptor — PubMed: cubilin-amnionless receptor
  5. B12 safety at high doses (no UL established) — PubMed: B12 high-dose safety
  6. Transcobalamin II (TCN2 gene) transport polymorphism — PubMed: TCN2 polymorphism
  7. B12 reference range adequacy debate (200-900 pg/mL too broad) — PubMed: B12 reference range
  8. Enterohepatic recirculation of B12 — PubMed: enterohepatic B12 cycling
  9. Folic acid fortification and masking of B12 deficiency — PubMed: fortification + B12
  10. Nitrous oxide recreational use and B12 myeloneuropathy — PubMed: nitrous oxide whippets myeloneuropathy

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents